Performance of gene-expression profiling test score variability to predict future clinical events in heart transplant recipients

BACKGROUND: A single non-invasive gene expression profiling (GEP) test (AlloMap®) is often used to discriminate if a heart transplant recipient is at a low risk of acute cellular rejection at time of testing. In a randomized trial, use of the test (a GEP score from 0–40) has been shown to be non-inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Crespo-Leiro, Maria G., Stypmann, Jörg, Schulz, Uwe, Zuckermann, Andreas, Mohacsi, Paul, Bara, Christoph, Ross, Heather, Parameshwar, Jayan, Zakliczyński, Michal, Fiocchi, Roberto, Hoefer, Daniel, Deng, Mario, Leprince, Pascal, Hiller, David, Eubank, Lane, Deljkich, Emir, Yee, James P., Vanhaecke, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600291/
https://www.ncbi.nlm.nih.gov/pubmed/26452346
http://dx.doi.org/10.1186/s12872-015-0106-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600291/
https://www.ncbi.nlm.nih.gov/pubmed/26452346
http://dx.doi.org/10.1186/s12872-015-0106-1

Ejemplares similares